Related Experiment Video
Updated: Apr 10, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Ischemic stroke as a complex polygenic disease]
Insights
Genetic factors contribute to ischemic stroke (IS), a major health issue. Identifying these genetic predispositions is challenging due to inconsistent results, requiring studies in homogeneous populations.
Area of Science:
- Genetics
- Neurology
- Public Health
Context:
- Acute cerebrovascular accidents, particularly ischemic stroke (IS), represent a significant global health challenge.
- IS is a complex, multifactorial polygenic disease influenced by genetic components and environmental risk factors.
- Current research employs candidate gene and genome-wide association studies to identify genetic predispositions to IS.
Purpose:
- To review existing literature on the genetic susceptibility to ischemic stroke.
- To assess the progress and challenges in identifying genetic risk factors for IS.
- To highlight future research directions for understanding IS pathophysiology.
Summary:
- The review indicates progress in identifying genetic factors for IS but notes significant challenges in replicating findings.
- The polygenic nature of IS, involving interactions between genes and risk factors, complicates genetic association studies.
- Low replication rates hinder the development of reliable genetic risk prediction models for IS.
Impact:
- Advances in understanding IS genetic susceptibility can inform the study of its molecular mechanisms.
- Improved identification of genetic risk factors may lead to personalized IS prognosis.
- Focusing on ethnically homogeneous populations and specific IS subtypes could improve research reproducibility.
Abstract:
In the modern world acute cerebrovascular accidents (strokes) are one of the most important sociomedical problems due to their high share in the structure of morbidity, invalidization and mortality of the population. The main part of strokes is ischemic stroke (IS). IS is a complex (multifactorial) polygenic disease, i.e. develops as a result of interactions between risk factors and genetic components that determine a joint contribution of the sets of independently acting or interacting polymorphic genes. Currently, the search for a genetic predisposition to IS uses two main methods that are based on the analysis of the association between the polymorphic regions of the genome and disease: a candidate gene approach and genome-wide association studies, followed by a meta-analysis of the received results. In this work we reviewed the literature on genetic susceptibility to IS. It showed progress in this direction, which can be the starting point for the study of the molecular mechanisms determining the pathophysiology of IS. However to a full solution of the problem of identification of the genetic risk factors applicable for the individual prognosis of predisposition to IS, still very far, mainly due to the low replication of results. The way to solve this problem lies through the study of ethnically homogeneous populations and clinically different forms of IS.
More Related Videos
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
05:32Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model
Published on: August 11, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
Polygenic Traits
Polygenic Traits
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Coronary Artery Disease II: Pathophysiology